Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ballerini

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Leukemia|November 20, 2009
Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activityB Gerby, F Armstrong, P B de la Grange, et al.
Leukemia|April 20, 2012
RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiationP Ballerini, S Struski, C Cresson, et al.
Oncogene|January 29, 2014
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemiaE Pasmant, B Gilbert-Dussardier, A Petit, et al.
Leukemia|September 16, 2018
Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALLC Prieto, B López-Millán, H Roca-Ho, et al.
Leukemia|September 26, 2017
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALLC Prieto, B López-Millán, H Roca-Ho, et al.
Leukemia|September 13, 2003
t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)R Berger, N Dastugue, M Busson, et al.
Leukemia|April 5, 2023
The KMT2A recombinome of acute leukemias in 2023C Meyer, P Larghero, B Almeida Lopes, et al.
Leukemia|July 14, 2017
The MLL recombinome of acute leukemias in 2017C Meyer, T Burmeister, D Gröger, et al.
Leukemia|May 1, 2013
The MLL recombinome of acute leukemias in 2013C Meyer, J Hofmann, T Burmeister, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Leukemia|November 20, 2009
Optimized gene transfer into human primary leukemic T cell with NOD-SCID/leukemia-initiating cell activityB Gerby, F Armstrong, P B de la Grange, et al.
Leukemia|April 20, 2012
RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiationP Ballerini, S Struski, C Cresson, et al.
Oncogene|January 29, 2014
SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemiaE Pasmant, B Gilbert-Dussardier, A Petit, et al.
Leukemia|September 16, 2018
Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALLC Prieto, B López-Millán, H Roca-Ho, et al.
Leukemia|September 26, 2017
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALLC Prieto, B López-Millán, H Roca-Ho, et al.
Leukemia|September 13, 2003
t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)R Berger, N Dastugue, M Busson, et al.
Leukemia|April 5, 2023
The KMT2A recombinome of acute leukemias in 2023C Meyer, P Larghero, B Almeida Lopes, et al.
Leukemia|July 14, 2017
The MLL recombinome of acute leukemias in 2017C Meyer, T Burmeister, D Gröger, et al.
Leukemia|May 1, 2013
The MLL recombinome of acute leukemias in 2013C Meyer, J Hofmann, T Burmeister, et al.
Pageof 9